Page 263 - Drug Class Review
P. 263
Drug Effectiveness Review Project
Alzheimer Drugs Authors: Dunn et al. 84 Year: 2000 Country: UK Drug and Safety Research Unit To report the incidence of adverse events associated with DON Study design: Observational cohort pharmacovigilance study (prescription event monitoring) Setting: Questionnaires to general practitioners in the UK Sample size: 3,356 questionnaires sent; 1,762 returned donepezil N/A N/A 1,762 Patients who received DON within the first few months of its launch NR NR Page 162 of 205
Final Report Update 1 Adverse Events STUDY: FUNDING: RESEARCH OBJECTIVE: DESIGN: INTERVENTION: Dose: Duration: Sample size: INCLUSION: EXCLUSION: OTHER MEDICATIONS/ INTERVENTIONS ALLOWED: Alzheimer's Drugs
